By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Syros Pharmaceuticals 

480 Arsenal Street
Suite 130
Watertown  Massachusetts  02472  U.S.A,
Phone: 617-744-1340 Fax: n/a


SEARCH JOBS

We are a therapeutics company passionately committed to applying our scientific leadership in the emerging field of gene control to transform the lives of patients with cancer and other diseases.

Founded by world-leading experts in gene regulation, and led by a seasoned management team, Syros is focused on developing new medicines that control genes that cause disease. Central to our approach is a proprietary drug development platform of integrated gene control assay technologies, computational biology, chemistry, and deep biologic insights that gives us an unprecedented understanding of and control over gene regulation. Our pioneering research and drug development capabilities provide us with the distinctive ability to identify new, important disease and patient-targeted gene control medicines.


Key Statistics


Email: info@Syros.com
Ownership: Private

Web Site: Syros Pharmaceuticals
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
Syros Pharmaceuticals Presents Research On Gene Control In Acute Myeloid Leukemia At AACR Hematologic Malignancies Meeting 9/23/2014 9:51:34 AM
Syros Pharmaceuticals Appoints Genomics Entrepreneur Jorge Conde To Dual Role As Chief Financial Officer And Chief Product Officer 6/10/2014 6:54:59 AM
Richard A. Young, Syros Pharmaceuticals Scientific Founder, To Open American Association for Cancer Research Annual Meeting 2014 With Address Highlighting His Pioneering Gene Control Research 4/2/2014 7:40:46 AM
Syros Pharmaceuticals Announces Publication Of Important Scientific Studies Related To Company's Industry-Leading Gene Control Platform 12/18/2013 9:25:47 AM
Dr. Nathanael Gray, A Syros Pharmaceuticals Scientific Founder, Honored With 2013 Meyenburg Cancer Research Award 12/16/2013 8:14:48 AM
Syros Pharmaceuticals Appoints St├ęphane Bancel to Board of Directors 11/21/2013 7:48:09 AM
Syros Pharmaceuticals Appoints Vicki L. Sato, Ph.D., to Board of Directors 9/5/2013 9:23:21 AM
//-->